AstraZeneca - Research-Based BioPharmaceutical Company

Skip to content
Skip to navigation
Skip to footer

Our sustainability ambition

"2021 has been a defining year for sustainability and climate action, with a heightened awareness of the need to protect and invest in the health of people, ecosystems and our planet. We have a long-standing commitment to delivering sustainable healthcare and will continue to partner with stakeholders to help people stay well, communities to thrive, and society to build back post pandemic."

Katarina Ageborg, Executive Vice-President Sustainability and Chief Compliance Officer

Find out more about our sustainability strategy and approach

Publications

Our innovative science means a strong track-record of publication in peer-reviewed journals, contributing to the foundation of scientific advancement.

View our publications

We have

175

projects in our pipeline

View pipeline

Explore our technology

Our Cambridge site (UK) is one of AstraZeneca's three global science centres

Explore all our science centres

Creating sustainable healthcare and a sustainable planet for all requires collaboration at scale and pace. No organisation, government, or institution can do it alone. As we have seen throughout the pandemic, public-private partnerships can deliver innovation worldwide, at speed and at scale.

Corporate Press Release

Enhertu granted Priority Review in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen

17 January 2022

Corporate Press Release

AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data at ASCO GI and GU

13 January 2022